In Re Finjan Holdings, Inc. Securities Litigation

District Court, N.D. California·Decided September 13, 2021·No. 3:20-cv-04289·Unknown

Opinion

IN RE FINJAN HOLDINGS, INC. Case No. 20-cv-04289-EMC SECURITIES LITIGATION. ORDER GRANTING DEFENDANTS’ MOTION TO DISMISS SECOND AMENDED COMPLAINT Docket No. 46

The above-referenced case is a securities action filed against Finjan Holdings, Inc. (“Finjan”) and its President and CEO Philip Hartstein.1 Lead Plaintiff (an individual, Robert Grier) asserts that Defendants violated §§ 14(e) and 20(a) of the Securities Exchange Act of 1934 based on misrepresentations related to a tender offer in which Fortress Investment Group LLC, through an affiliate, acquired all of Finjan’s stock for $1.55 per share. The alleged misrepresentations were contained in the Recommendation Statement (Schedule 14D-9) and/or amendments thereto that Defendants disseminated to Finjan shareholders prior to their making a decision on whether to tender their shares in the offer. See generally Defs.’ RJN, Ex. A (Rec. St. at 12) (stating that, the Board unanimously “determined that the Offer, the Merger and the other transactions contemplated by the Merger Agreement are fair to and in the best interests of the Company and its stockholders” and “recommended that the stockholders of the Company tender their Shares in the Offer”). Previously, the Court dismissed Lead Plaintiff’s first amended complaint (“FAC”) based on failure to plead subjective falsity. Lead Plaintiff, however, was given leave to amend, and thus he filed the operative second amended complaint (“SAC”). Now pending before the Court is Defendants’ motion to dismiss the SAC. The gist of Lead Plaintiff’s suit is that Defendants made material misrepresentations about the value of the company (i.e., undervaluing it). Specifically, in the Recommendation Statement issued in June 2020, Defendants claimed that Fortress’s offer of $1.55 per share was reasonable based on financial projections that Finjan would have revenues of about $166 million for the period 2020-2024.2 However, just six months earlier, in December 2019, Defendants claimed that Finjan expected to generate approximately $200-400 million in revenue for the period 2019-2022 – and this was with respect to just one line of business (licensing and enforcement) out of three. Lead Plaintiff contends that nothing happened in the six-month period that would have warranted such a drastic reduction in the value of the company. In fact, Lead Plaintiff asserts, Finjan management made optimistic statements during the six-month period and further indicated that COVID-19 would not be an issue (e.g., even if trials would be delayed, they would still take place before 2024 and thus projected revenue might be delayed but not altogether eliminated). Lead Plaintiff also maintains that third parties also viewed Finjan favorably during this six-month period. See, e.g., SAC ¶ 67 (alleging that “Dmitriy Kozin, a sophisticated Finjan investor who closely followed the Company, explained in an article entitled ‘COVID-19 or not, Finjan should do well,’ the Company was ‘realistically worth 3x more than [its then] current share price and potentially 10x more’”); SAC ¶ 129 (alleging that, in an article dated May 18, 2020, “Investor Observer, a financial investment website, noted that “‘the average rating from Wall Street analysts, FNJN stock has a mean target price of $5,’” which “‘means analysts expect the stock to rise 252.11% over the next 12 months’”). A. Prior 12(b)(6) Proceedings During the prior 12(b)(6) proceedings, the Court noted that Lead Plaintiff had to make a plausible showing of both objective and subjective falsity in order to have a viable claim. The Court did not make a definitive ruling on objective falsity. See Docket No. 18 (Order at 18-19) (acknowledging allegations made by Lead Plaintiff but also noting that there were facts that indicated the tender offer was fair – e.g., (1) “in the months preceding the tender offer, the stock had not always performed well and/or revenues were low”; (2) “[t]he merger consideration of $1.55 per share was more than the then-current stock price”; (3) “Party B had made an offer ($1.50 per share) that was similar in value to the merger consideration, and there were no other suitors”; (4) “[u]nder the Premiums Paid Analysis (also part of the Fairness Opinion), Atlas found that the value of Finjan stock could be as low as $1.56 per share”; and (5) there was “uncertainty in the future, both because of COVID-19 and the nature of Finjan’s business (patent licensing and enforcement which involves extended negotiations and at times litigation”; but ultimately not resolving the issue of objective falsity). However, the Court held that Lead Plaintiff failed to allege a viable claim because subjectively falsity was insufficiently pled. Subjective falsity meant that Lead Plaintiff had to plead “facts giving rise to a strong inference that Defendants did not believe [the financial projections of $166 million for the 2020-2024 period] were true – i.e., that Defendants knew that the [financial projections] were false even though they were presenting them to Atlas as true for purposes of developing the Fairness Opinion.” Docket No. 41 (Order at 20) (emphasis in original). The Court noted that, “[i]n a recent opinion, the Ninth Circuit underscored that, if a ‘complaint fails to plead a plausible motive for the allegedly fraudulent action, the plaintiff will face a substantial hurdle in establishing scienter.’” Docket No. 41 (Order at 20). Here, Lead Plaintiff’s FAC did not explain why Defendants would endorse the financial projections as true if they actually believed them to be false.

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Finjan Holdings, Inc. Securities Litigation, (N.D. Cal. 2021).

In Re Finjan Holdings, Inc. Securities Litigation (In Re Finjan Holdings, Inc. Securities Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Melder v. Morris
27 F.3d 1097 (Fifth Circuit, 1994)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Manzarek v. St. Paul Fire & Marine Insurance
519 F.3d 1025 (Ninth Circuit, 2008)
Glazer Capital Management, LP v. Magistri
549 F.3d 736 (Ninth Circuit, 2008)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)
Kalnit v. Eichler
264 F.3d 131 (Second Circuit, 2001)